MSc Manufacture and Commercialisation of Stem Cell and Gene Therapies

The "Manufacture and Commercialisation of Stem Cell and Gene Therapies MSc" is a one year full time, or two years part-time, graduate program offered by the University College London (UCL). This course provides cutting-edge insight into the rapidly evolving field of Stem Cell and Gene Therapies. It combines the expertise of UCL’s Department of Biochemical Engineering, Advanced Centre for Biochemical Engineering and the Division of Medicine to deliver a comprehensive curriculum on the current and potential impact of these therapies.Course Content: Throughout the course, students will gain valuable knowledge on the scientific basis of stem cell and gene therapy, comprehend their current clinical use, and the challenges in their manufacture and clinical application. They will also learn about the bioprocess techniques necessary for successful stem cell and gene therapy manufacture.Key Modules: The key modules enclosed in the course curriculum include Introductory Biosciences, Bioprocess Design & Economic Analysis, Cell Therapy Bioprocess, Gene Therapy Bioprocess, and Clinical Translation & Commercialisation of Cell & Gene Therapy, among others. Accreditations: There is no specific accreditation information mentioned on the website.Future Careers: Graduates from this program may secure positions in the bioprocessing industry (where stem cells are being utilised for drug discovery), the pharmaceutical sector (which are developing cell and gene therapies), regulatory bodies, or potentially embark on further academic study.For more information on this course, please visit the official course page here.